Skip to content

Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression

Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734291
Enrollment
49
Registered
2012-11-27
Start date
2012-10-01
Completion date
2016-10-09
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Family psychoeducation, Major depressive disorder, Family burden

Brief summary

The purpose of this study is to examine the effectiveness of brief multifamily psychoeducation to relieve the psychological distress of families of patients with chronic major depression and to improve their family functioning.

Detailed description

Major depressive disorder (MDD) is a long-lasting illness with significant effects on the patient's family, social life, and work life. Treatment failure results in a low recovery rate and frequent relapses. Relatives of patients with MDD are fraught with heavy psychosocial burden and show increased rates of depression and anxiety. Among relatives of patients with MDD, the patient's behavior and mood disturbance and relative's emotional distress were associated with the relatives' burden. Family psychoeducation is recognized as part of the optimal treatment for patients with psychotic disorder. This intervention has been shown to reduce the rates of relapse and hospitalization among individuals with psychotic disorders and is recognized as an evidenced-based treatment for psychotic disorder. Several randomized controlled trials have found that family psychoeducation is effective in enhancing the course of bipolar disorder. However, there are few studies on psychoeducation of families of patients with MDD. The purpose of this study is to examine the effectiveness of brief multifamily psychoeducation to relieve the psychological distress of families of patients with chronic major depression and to improve their family functioning, in a randomized controlled trial.

Interventions

Family psychoeducational therapy every two weeks for six weeks in addition to treatment as usual administered by physicians

Sponsors

Nagoya City University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Meets the criteria for Major Depressive Disorder (MDD) according to DSM-IV. 2. Receives antidepressant therapy. 3. The patient had the first episode of MDD more than one year ago. 4. Currently fulfills the diagnostic threshold for major depressive episode or partial remission. 5. The patient and their family member(s) are aged between 18 and 85 years. 6. The patient has lived with his/her family at the time of participating in this study and is expected to live with his/her family during the investigation period.

Exclusion criteria

1. Patients who undergo electroconvulsive therapy (ECT) during the investigation period. 2. Patients who are at serious suicidal risk.

Design outcomes

Primary

MeasureTime frameDescription
The change of total score of K6 of family membersThe base line, 8, 16 and 32The K6 questionnaire is a six-item self-report questionnaire that was developed to screen for DSM-IV depressive and anxiety disorder.

Secondary

MeasureTime frameDescription
The change of total score of Family Attitude Scale(FAS) of family membersThe base line, 8, 16 and 32The Family Attitude Scale(FAS) is a 30-item self report inventory and measures families' Expressed Emotion(EE).

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026